Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
N

NTRA

Nasdaq

Natera, Inc.

Latest disclosureOctober 2, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 273 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 310

Limited filing history
All310Buying0Selling273Other37
Filters

Last 30 daysNo qualifying insider buying. Sales: $63.19M by 4 insiders.

273 of 310 trades · March 31, 2026 – October 1, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 273 trades on this page.

Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$526.14K
Reported price
$413.31 / share
Traded October 1, 2026Filed October 2, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$82.32K
Reported price
$411.62 / share
Traded October 1, 2026Filed October 2, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$394.1K
Reported price
$413.1066 / share
Traded October 1, 2026Filed October 2, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$766.22K
Reported price
$415.0691 / share
Traded October 1, 2026Filed October 2, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$154.04K
Reported price
$385.1025 / share
Traded September 23, 2026Filed September 25, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$841.1K
Reported price
$386.7144 / share
Traded September 23, 2026Filed September 25, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$1.06M
Reported price
$387.6545 / share
Traded September 23, 2026Filed September 25, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$502.6K
Reported price
$388.7071 / share
Traded September 23, 2026Filed September 25, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$904.07K
Reported price
$389.685 / share
Traded September 23, 2026Filed September 25, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$42.95K
Reported price
$390.42 / share
Traded September 23, 2026Filed September 25, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$150.26K
Reported price
$385.2906 / share
Traded September 23, 2026Filed September 25, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$889.27K
Reported price
$386.6396 / share
Traded September 23, 2026Filed September 25, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$1.1M
Reported price
$387.7351 / share
Traded September 23, 2026Filed September 25, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$521.33K
Reported price
$388.7637 / share
Traded September 23, 2026Filed September 25, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$754.09K
Reported price
$389.7108 / share
Traded September 23, 2026Filed September 25, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$85.92K
Reported price
$390.525 / share
Traded September 23, 2026Filed September 25, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$2.1M
Reported price
$350.0718 / share
Traded September 15, 2026Filed September 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$69.61K
Reported price
$348.025 / share
Traded September 16, 2026Filed September 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$34.9K
Reported price
$349.045 / share
Traded September 16, 2026Filed September 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$495.36K
Reported price
$353.83 / share
Traded September 16, 2026Filed September 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$159.71K
Reported price
$354.9133 / share
Traded September 16, 2026Filed September 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$284.76K
Reported price
$355.9475 / share
Traded September 16, 2026Filed September 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$71.37K
Reported price
$356.8664 / share
Traded September 16, 2026Filed September 17, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$504.28K
Reported price
$328.0942 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$1.98M
Reported price
$329.1171 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$2.05M
Reported price
$330.0514 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$1.16M
Reported price
$330.9752 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$332.02K
Reported price
$332.0169 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$748.07K
Reported price
$333.0656 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$941.88K
Reported price
$334.2362 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$1.26M
Reported price
$335.1805 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$2.84M
Reported price
$336.266 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$744.13K
Reported price
$337.169 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$473.61K
Reported price
$338.296 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$712.67K
Reported price
$339.3681 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$680.63K
Reported price
$340.313 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$921.64K
Reported price
$341.3467 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$1.39M
Reported price
$342.5067 / share
Traded September 14, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$502.41K
Reported price
$339.2351 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$867.29K
Reported price
$340.2485 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$618.97K
Reported price
$341.4067 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$669.3K
Reported price
$342.1804 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$769.58K
Reported price
$343.5638 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$2.01M
Reported price
$344.4859 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$932.53K
Reported price
$345.3798 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$388.97K
Reported price
$346.6751 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$939.09K
Reported price
$347.8127 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$2.82M
Reported price
$348.6465 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$1.47M
Reported price
$349.5097 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$5.09M
Reported price
$350.8069 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$281K
Reported price
$351.245 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$700.01K
Reported price
$350.0072 / share
Traded September 15, 2026Filed September 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$260.01K
Reported price
$325.0075 / share
Traded September 11, 2026Filed September 11, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$1.19M
Reported price
$326.1077 / share
Traded September 11, 2026Filed September 11, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$3.45M
Reported price
$327.1442 / share
Traded September 11, 2026Filed September 11, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$5.88M
Reported price
$327.9724 / share
Traded September 11, 2026Filed September 11, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$5.19M
Reported price
$328.9502 / share
Traded September 11, 2026Filed September 11, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$428.51K
Reported price
$329.6247 / share
Traded September 11, 2026Filed September 11, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$319.76K
Reported price
$319.7582 / share
Traded September 1, 2026Filed September 3, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$449.29K
Reported price
$320.9225 / share
Traded September 1, 2026Filed September 3, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$193.14K
Reported price
$321.9067 / share
Traded September 1, 2026Filed September 3, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$4.96M
Reported price
$326.894 / share
Traded September 2, 2026Filed September 3, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$545.04K
Reported price
$320.99 / share
Traded September 1, 2026Filed September 3, 2026SEC filing
Sale disclosed

John Fesko

PRESIDENT, CHIEF BUS. OFFICER

Common Stock

Reported value
$2.1M
Reported price
$321.53 / share
Traded August 10, 2026Filed August 28, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$1.95M
Reported price
$325.3237 / share
Traded August 10, 2026Filed August 14, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$641.8K
Reported price
$320.90 / share
Traded August 7, 2026Filed August 7, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$30.84K
Reported price
$308.40 / share
Traded August 7, 2026Filed August 7, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$124.09K
Reported price
$310.225 / share
Traded August 7, 2026Filed August 7, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$124.75K
Reported price
$311.8788 / share
Traded August 7, 2026Filed August 7, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$281.76K
Reported price
$313.0672 / share
Traded August 7, 2026Filed August 7, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$267.11K
Reported price
$314.2517 / share
Traded August 7, 2026Filed August 7, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$189.19K
Reported price
$315.3175 / share
Traded August 7, 2026Filed August 7, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$1.62M
Reported price
$316.6118 / share
Traded August 7, 2026Filed August 7, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$63.59K
Reported price
$317.965 / share
Traded August 7, 2026Filed August 7, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$31.86K
Reported price
$318.63 / share
Traded August 7, 2026Filed August 7, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$156.92K
Reported price
$320.90 / share
Traded August 7, 2026Filed August 7, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$84.95K
Reported price
$267.9893 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$131.08K
Reported price
$274.22 / share
Traded August 4, 2026Filed August 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$316.76K
Reported price
$267.9893 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$41.6K
Reported price
$259.98 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$18.27K
Reported price
$261.025 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$178.37K
Reported price
$263.8622 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$21.22K
Reported price
$265.27 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$79.06K
Reported price
$267.0838 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$164.15K
Reported price
$268.2187 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

John Fesko

PRESIDENT, CHIEF BUS. OFFICER

Common Stock

Reported value
$79.06K
Reported price
$267.9893 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$109.88K
Reported price
$267.9893 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$77.99K
Reported price
$259.98 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$52.3K
Reported price
$261.4875 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$249.95K
Reported price
$263.9415 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$50.93K
Reported price
$265.275 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$330.18K
Reported price
$267.7869 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$34.39K
Reported price
$268.6964 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$89.51K
Reported price
$267.9893 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$195.9K
Reported price
$267.9893 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$29.21K
Reported price
$267.9893 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$75.02K
Reported price
$260.4908 / share
Traded July 27, 2026Filed July 29, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$48.53K
Reported price
$254.0696 / share
Traded July 28, 2026Filed July 29, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$447.52K
Reported price
$260.4908 / share
Traded July 27, 2026Filed July 29, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$230.27K
Reported price
$260.4908 / share
Traded July 27, 2026Filed July 29, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$254.83K
Reported price
$254.0704 / share
Traded July 28, 2026Filed July 29, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$263.1K
Reported price
$260.4908 / share
Traded July 27, 2026Filed July 29, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$305.9K
Reported price
$254.0705 / share
Traded July 28, 2026Filed July 29, 2026SEC filing
Sale disclosed

John Fesko

PRESIDENT, CHIEF BUS. OFFICER

Common Stock

Reported value
$203.7K
Reported price
$260.4908 / share
Traded July 27, 2026Filed July 29, 2026SEC filing
Sale disclosed

John Fesko

PRESIDENT, CHIEF BUS. OFFICER

Common Stock

Reported value
$236.54K
Reported price
$254.0705 / share
Traded July 28, 2026Filed July 29, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$570.47K
Reported price
$260.4908 / share
Traded July 27, 2026Filed July 29, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$909.57K
Reported price
$254.0704 / share
Traded July 28, 2026Filed July 29, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$203.7K
Reported price
$260.4908 / share
Traded July 27, 2026Filed July 29, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$315.3K
Reported price
$254.0705 / share
Traded July 28, 2026Filed July 29, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$255.8K
Reported price
$253.7672 / share
Traded July 28, 2026Filed July 29, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$43.24K
Reported price
$254.3338 / share
Traded July 28, 2026Filed July 29, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$464.59K
Reported price
$249.38 / share
Traded July 29, 2026Filed July 29, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$122.87K
Reported price
$273.0473 / share
Traded July 15, 2026Filed July 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$24.68K
Reported price
$274.2589 / share
Traded July 15, 2026Filed July 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$46.79K
Reported price
$275.2644 / share
Traded July 15, 2026Filed July 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$11.06K
Reported price
$276.38 / share
Traded July 15, 2026Filed July 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$106.47K
Reported price
$273.0088 / share
Traded July 15, 2026Filed July 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$27.37K
Reported price
$273.684 / share
Traded July 15, 2026Filed July 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$49.5K
Reported price
$274.9858 / share
Traded July 15, 2026Filed July 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$22.08K
Reported price
$276.015 / share
Traded July 15, 2026Filed July 17, 2026SEC filing
Sale disclosed

Rowan E. Chapman

Director

Common Stock

Reported value
$37.1K
Reported price
$274.82 / share
Traded July 15, 2026Filed July 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$131.36K
Reported price
$262.716 / share
Traded July 13, 2026Filed July 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$211.44K
Reported price
$264.2944 / share
Traded July 13, 2026Filed July 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$106.06K
Reported price
$265.1488 / share
Traded July 13, 2026Filed July 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$133.38K
Reported price
$266.754 / share
Traded July 13, 2026Filed July 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$120.47K
Reported price
$267.7216 / share
Traded July 13, 2026Filed July 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$134.19K
Reported price
$268.387 / share
Traded July 13, 2026Filed July 15, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$280K
Reported price
$280.00 / share
Traded July 6, 2026Filed July 8, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$418.33K
Reported price
$266.7925 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$993.33K
Reported price
$268.1052 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$519.69K
Reported price
$268.9928 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$130.62K
Reported price
$269.8672 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$367.7K
Reported price
$270.9645 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$123.55K
Reported price
$272.1388 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$137.1K
Reported price
$274.1908 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$302.72K
Reported price
$275.1972 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$386.74K
Reported price
$276.2425 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$567.06K
Reported price
$277.2889 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$543.97K
Reported price
$278.247 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$83.63K
Reported price
$278.7667 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$26.72K
Reported price
$267.185 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$709.77K
Reported price
$272.99 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$82.22K
Reported price
$274.06 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$4.06M
Reported price
$250.2491 / share
Traded June 24, 2026Filed June 26, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$301.91K
Reported price
$251.5958 / share
Traded June 24, 2026Filed June 26, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$1.28M
Reported price
$252.3076 / share
Traded June 24, 2026Filed June 26, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$2.82M
Reported price
$253.3884 / share
Traded June 24, 2026Filed June 26, 2026SEC filing
Sale disclosed

Herm Rosenman

Director

Common Stock

Reported value
$4.13M
Reported price
$250.00 / share
Traded June 24, 2026Filed June 26, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$55.84K
Reported price
$218.1371 / share
Traded June 17, 2026Filed June 22, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$28.06K
Reported price
$219.2576 / share
Traded June 17, 2026Filed June 22, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$26.95K
Reported price
$220.9254 / share
Traded June 17, 2026Filed June 22, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$54.04K
Reported price
$221.4641 / share
Traded June 17, 2026Filed June 22, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$58.25K
Reported price
$218.1752 / share
Traded June 17, 2026Filed June 22, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$21.04K
Reported price
$219.1321 / share
Traded June 17, 2026Filed June 22, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$15.65K
Reported price
$220.4632 / share
Traded June 17, 2026Filed June 22, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$66.64K
Reported price
$221.3855 / share
Traded June 17, 2026Filed June 22, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$3.33K
Reported price
$222.144 / share
Traded June 17, 2026Filed June 22, 2026SEC filing
Sale disclosed

Rowan E. Chapman

Director

Common Stock

Reported value
$642.54K
Reported price
$216.78 / share
Traded June 16, 2026Filed June 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$368.01K
Reported price
$210.2921 / share
Traded June 15, 2026Filed June 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$126.8K
Reported price
$211.3375 / share
Traded June 15, 2026Filed June 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$106.21K
Reported price
$212.424 / share
Traded June 15, 2026Filed June 17, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$64.06K
Reported price
$213.5383 / share
Traded June 15, 2026Filed June 17, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$531.28K
Reported price
$209.4953 / share
Traded June 12, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$687.05K
Reported price
$210.2993 / share
Traded June 12, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$625.74K
Reported price
$211.6121 / share
Traded June 12, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$2.58M
Reported price
$212.2716 / share
Traded June 12, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$1.07M
Reported price
$213.4284 / share
Traded June 12, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$1.22M
Reported price
$214.351 / share
Traded June 12, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$680.82K
Reported price
$215.3797 / share
Traded June 12, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$1.55M
Reported price
$216.5078 / share
Traded June 12, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$929.28K
Reported price
$217.3242 / share
Traded June 12, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$465.36K
Reported price
$218.17 / share
Traded June 12, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$352.07K
Reported price
$219.3581 / share
Traded June 12, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$174.37K
Reported price
$209.8343 / share
Traded June 15, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$386.06K
Reported price
$210.73 / share
Traded June 15, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$262.01K
Reported price
$211.8092 / share
Traded June 15, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$1.08M
Reported price
$212.8363 / share
Traded June 15, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$1.68M
Reported price
$213.8846 / share
Traded June 15, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$2.22M
Reported price
$214.7173 / share
Traded June 15, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$2.56M
Reported price
$215.9079 / share
Traded June 15, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$1.46M
Reported price
$216.8135 / share
Traded June 15, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$829.28K
Reported price
$217.6027 / share
Traded June 15, 2026Filed June 16, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$87.49K
Reported price
$218.7225 / share
Traded June 15, 2026Filed June 16, 2026SEC filing
Sale disclosed

Gail Boxer Marcus

Director

Common Stock

Reported value
$651.65K
Reported price
$216.0631 / share
Traded June 5, 2026Filed June 9, 2026SEC filing
Sale disclosed

Gail Boxer Marcus

Director

Common Stock

Reported value
$1.02M
Reported price
$217.3036 / share
Traded June 5, 2026Filed June 9, 2026SEC filing
Sale disclosed

Gail Boxer Marcus

Director

Common Stock

Reported value
$692.28K
Reported price
$218.1084 / share
Traded June 5, 2026Filed June 9, 2026SEC filing
Sale disclosed

Gail Boxer Marcus

Director

Common Stock

Reported value
$25.38K
Reported price
$218.815 / share
Traded June 5, 2026Filed June 9, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$176.73K
Reported price
$212.4187 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$534.25K
Reported price
$213.444 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$279.28K
Reported price
$214.83 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$1.19M
Reported price
$216.1344 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$510.26K
Reported price
$217.0396 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$380.25K
Reported price
$218.2847 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$604.22K
Reported price
$219.0806 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$528.45K
Reported price
$220.1875 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$445.83K
Reported price
$222.2469 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$1.45M
Reported price
$223.3354 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$323.1K
Reported price
$223.9093 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$366.74K
Reported price
$224.9918 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$1.53M
Reported price
$226.1472 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$773.74K
Reported price
$226.9699 / share
Traded June 4, 2026Filed June 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$391.97K
Reported price
$217.5199 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$90.38K
Reported price
$218.8445 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$46.72K
Reported price
$219.34 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$126.22K
Reported price
$220.6674 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Roelof Botha

Director

Common Stock

Reported value
$5.78M
Reported price
$218.6881 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Roelof Botha

Director

Common Stock

Reported value
$2.22M
Reported price
$219.7768 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Roelof Botha

Director

Common Stock

Reported value
$4.71M
Reported price
$220.9419 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Roelof Botha

Director

Common Stock

Reported value
$3.3M
Reported price
$221.5848 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Roelof Botha

Director

Common Stock

Reported value
$634.96K
Reported price
$222.7944 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Roelof Botha

Director

Common Stock

Reported value
$548.37K
Reported price
$223.8265 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$335.09K
Reported price
$202.8398 / share
Traded May 26, 2026Filed May 28, 2026SEC filing
Sale disclosed

John Fesko

PRESIDENT, CHIEF BUS. OFFICER

Common Stock

Reported value
$291.68K
Reported price
$202.8398 / share
Traded May 26, 2026Filed May 28, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$41.09K
Reported price
$205.43 / share
Traded May 8, 2026Filed May 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$186.52K
Reported price
$207.2411 / share
Traded May 8, 2026Filed May 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$145.69K
Reported price
$208.1286 / share
Traded May 8, 2026Filed May 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$41.91K
Reported price
$209.5725 / share
Traded May 8, 2026Filed May 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$241.9K
Reported price
$210.345 / share
Traded May 8, 2026Filed May 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$16.96K
Reported price
$199.5174 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$69.38K
Reported price
$201.1139 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$58.75K
Reported price
$202.5823 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$6.09K
Reported price
$202.84 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$19.15K
Reported price
$199.4346 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$72.43K
Reported price
$201.1923 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$57.76K
Reported price
$202.6829 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$1.83K
Reported price
$203.295 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$148.85K
Reported price
$206.16 / share
Traded May 4, 2026Filed May 6, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$596.94K
Reported price
$206.77 / share
Traded May 5, 2026Filed May 6, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$350.98K
Reported price
$241.39 / share
Traded May 5, 2026Filed May 6, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$350.89K
Reported price
$206.77 / share
Traded May 5, 2026Filed May 6, 2026SEC filing
Sale disclosed

Matthew Rabinowitz

EXECUTIVE CHAIRMAN

Common Stock

Reported value
$194.55K
Reported price
$205.22 / share
Traded May 5, 2026Filed May 6, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$64.53K
Reported price
$206.16 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$101.46K
Reported price
$210.49 / share
Traded May 4, 2026Filed May 5, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$22.06K
Reported price
$206.16 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$83.49K
Reported price
$206.16 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$112.53K
Reported price
$200.9523 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$104.83K
Reported price
$201.6004 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$102.67K
Reported price
$203.3155 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$176.86K
Reported price
$204.4657 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$82.12K
Reported price
$205.3075 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$31.04K
Reported price
$206.93 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

John Fesko

PRESIDENT, CHIEF BUS. OFFICER

Common Stock

Reported value
$59.99K
Reported price
$206.16 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$185.96K
Reported price
$206.16 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$68.03K
Reported price
$206.16 / share
Traded May 1, 2026Filed May 5, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$157.09K
Reported price
$203.75 / share
Traded April 27, 2026Filed April 29, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$249.76K
Reported price
$204.39 / share
Traded April 27, 2026Filed April 29, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$57.03K
Reported price
$190.115 / share
Traded April 29, 2026Filed April 29, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$96.06K
Reported price
$192.1286 / share
Traded April 29, 2026Filed April 29, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$193.78K
Reported price
$193.779 / share
Traded April 29, 2026Filed April 29, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$208.46K
Reported price
$194.822 / share
Traded April 29, 2026Filed April 29, 2026SEC filing
Sale disclosed

Michael Burkes Brophy

CHIEF FINANCIAL OFFICER

Common Stock

Reported value
$39.45K
Reported price
$197.26 / share
Traded April 29, 2026Filed April 29, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$462.92K
Reported price
$203.75 / share
Traded April 27, 2026Filed April 29, 2026SEC filing
Sale disclosed

Steven Leonard Chapman

CEO AND PRESIDENT

Common Stock

Reported value
$728.85K
Reported price
$204.39 / share
Traded April 27, 2026Filed April 29, 2026SEC filing
Sale disclosed

John Fesko

PRESIDENT, CHIEF BUS. OFFICER

Common Stock

Reported value
$157.09K
Reported price
$203.75 / share
Traded April 27, 2026Filed April 29, 2026SEC filing
Sale disclosed

John Fesko

PRESIDENT, CHIEF BUS. OFFICER

Common Stock

Reported value
$187.43K
Reported price
$204.39 / share
Traded April 27, 2026Filed April 29, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$203.14K
Reported price
$203.75 / share
Traded April 27, 2026Filed April 29, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$242.2K
Reported price
$204.39 / share
Traded April 27, 2026Filed April 29, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$177.87K
Reported price
$203.75 / share
Traded April 27, 2026Filed April 29, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$201.94K
Reported price
$204.39 / share
Traded April 27, 2026Filed April 29, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$58.07K
Reported price
$203.75 / share
Traded April 27, 2026Filed April 29, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$38.43K
Reported price
$204.39 / share
Traded April 27, 2026Filed April 29, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$444.62K
Reported price
$196.2151 / share
Traded April 29, 2026Filed April 29, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$158.58K
Reported price
$196.9876 / share
Traded April 29, 2026Filed April 29, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$149.75K
Reported price
$199.664 / share
Traded April 17, 2026Filed April 21, 2026SEC filing
Sale disclosed

Jonathan Sheena

Director

Common Stock

Reported value
$149.69K
Reported price
$199.5906 / share
Traded April 17, 2026Filed April 21, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$60.24K
Reported price
$200.7868 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$359.17K
Reported price
$202.0062 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$652.47K
Reported price
$203.072 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$244.59K
Reported price
$203.8258 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Sale disclosed

Daniel Rabinowitz

SEC. AND CHIEF LEGAL OFFICER

Common Stock

Reported value
$391.35K
Reported price
$205.0026 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$210.98K
Reported price
$201.3206 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$202.36K
Reported price
$202.3638 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Sale disclosed

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Common Stock

Reported value
$193.55K
Reported price
$203.3106 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
CEO AND PRESIDENTCommon StockSale10b5-11,273$413.31 / share$526.14KOct 1Filed Oct 2 · 1d laterSEC filing
PRESIDENT, CLINICALDIAGNOSTICSCommon StockSale10b5-13 trades3,000avg $414.22 / share$1.24MOct 1Filed Oct 2 · 1d later
3 filings
  • 200 @ $411.62 · $82.32KSEC filing
  • 954 @ $413.11 · $394.1KSEC filing
  • 1,846 @ $415.07 · $766.22KSEC filing
DirectorCommon StockSale10b5-112 trades18,064avg $388.01 / share$7.01MSep 23Filed Sep 25 · 2d later
12 filings
  • 400 @ $385.10 · $154.04KSEC filing
  • 2,175 @ $386.71 · $841.1KSEC filing
  • 2,734 @ $387.65 · $1.06MSEC filing
  • 1,293 @ $388.71 · $502.6KSEC filing
  • 2,320 @ $389.69 · $904.07KSEC filing
  • 110 @ $390.42 · $42.95KSEC filing
  • 390 @ $385.29 · $150.26KSEC filing
  • 2,300 @ $386.64 · $889.27KSEC filing
  • 2,846 @ $387.74 · $1.1MSEC filing
  • 1,341 @ $388.76 · $521.33KSEC filing
  • 1,935 @ $389.71 · $754.09KSEC filing
  • 220 @ $390.53 · $85.92KSEC filing
DirectorCommon StockSale10b5-16,000$350.07 / share$2.1MSep 15Filed Sep 17 · 2d laterSEC filing
DirectorCommon StockSale10b5-16 trades3,150avg $354.19 / share$1.12MSep 16Filed Sep 17 · 1d later
6 filings
  • 200 @ $348.03 · $69.61KSEC filing
  • 100 @ $349.05 · $34.9KSEC filing
  • 1,400 @ $353.83 · $495.36KSEC filing
  • 450 @ $354.91 · $159.71KSEC filing
  • 800 @ $355.95 · $284.76KSEC filing
  • 200 @ $356.87 · $71.37KSEC filing
EXECUTIVE CHAIRMANCommon StockSale10b5-115 trades50,000avg $334.76 / share$16.74MSep 14Filed Sep 16 · 2d later
15 filings
  • 1,537 @ $328.09 · $504.28KSEC filing
  • 6,015 @ $329.12 · $1.98MSEC filing
  • 6,206 @ $330.05 · $2.05MSEC filing
  • 3,494 @ $330.98 · $1.16MSEC filing
  • 1,000 @ $332.02 · $332.02KSEC filing
  • 2,246 @ $333.07 · $748.07KSEC filing
  • 2,818 @ $334.24 · $941.88KSEC filing
  • 3,754 @ $335.18 · $1.26MSEC filing
  • 8,459 @ $336.27 · $2.84MSEC filing
  • 2,207 @ $337.17 · $744.13KSEC filing
  • 1,400 @ $338.30 · $473.61KSEC filing
  • 2,100 @ $339.37 · $712.67KSEC filing
  • 2,000 @ $340.31 · $680.63KSEC filing
  • 2,700 @ $341.35 · $921.64KSEC filing
  • 4,064 @ $342.51 · $1.39MSEC filing
EXECUTIVE CHAIRMANCommon StockSale10b5-114 trades52,000avg $347.29 / share$18.06MSep 15Filed Sep 16 · 1d later
14 filings
  • 1,481 @ $339.24 · $502.41KSEC filing
  • 2,549 @ $340.25 · $867.29KSEC filing
  • 1,813 @ $341.41 · $618.97KSEC filing
  • 1,956 @ $342.18 · $669.3KSEC filing
  • 2,240 @ $343.56 · $769.58KSEC filing
  • 5,839 @ $344.49 · $2.01MSEC filing
  • 2,700 @ $345.38 · $932.53KSEC filing
  • 1,122 @ $346.68 · $388.97KSEC filing
  • 2,700 @ $347.81 · $939.09KSEC filing
  • 8,094 @ $348.65 · $2.82MSEC filing
  • 4,206 @ $349.51 · $1.47MSEC filing
  • 14,500 @ $350.81 · $5.09MSEC filing
  • 800 @ $351.25 · $281KSEC filing
  • 2,000 @ $350.01 · $700.01KSEC filing
EXECUTIVE CHAIRMANCommon StockSale10b5-16 trades50,000avg $327.97 / share$16.4MSep 11Filed Sep 11 · 0d later
6 filings
  • 800 @ $325.01 · $260.01KSEC filing
  • 3,647 @ $326.11 · $1.19MSEC filing
  • 10,556 @ $327.14 · $3.45MSEC filing
  • 17,933 @ $327.97 · $5.88MSEC filing
  • 15,764 @ $328.95 · $5.19MSEC filing
  • 1,300 @ $329.62 · $428.51KSEC filing
PRESIDENT, CLINICALDIAGNOSTICSCommon StockSale10b5-13 trades3,000avg $320.73 / share$962.19KSep 1Filed Sep 3 · 2d later
3 filings
  • 1,000 @ $319.76 · $319.76KSEC filing
  • 1,400 @ $320.92 · $449.29KSEC filing
  • 600 @ $321.91 · $193.14KSEC filing
PRESIDENT, CLINICALDIAGNOSTICSCommon StockSale10b5-115,160$326.89 / share$4.96MSep 2Filed Sep 3 · 1d laterSEC filing
CEO AND PRESIDENTCommon StockSale10b5-11,698$320.99 / share$545.04KSep 1Filed Sep 3 · 2d laterSEC filing
PRESIDENT, CHIEF BUS. OFFICERCommon StockSale10b5-16,517$321.53 / share$2.1MAug 10Filed Aug 28 · 18d laterSEC filing
DirectorCommon StockSale10b5-16,000$325.32 / share$1.95MAug 10Filed Aug 14 · 4d laterSEC filing
EXECUTIVE CHAIRMANCommon StockSale10b5-12,000$320.90 / share$641.8KAug 7Filed Aug 7 · 0d laterSEC filing
DirectorCommon StockSale10b5-110 trades9,150avg $315.66 / share$2.89MAug 7Filed Aug 7 · 0d later
10 filings
  • 100 @ $308.40 · $30.84KSEC filing
  • 400 @ $310.23 · $124.09KSEC filing
  • 400 @ $311.88 · $124.75KSEC filing
  • 900 @ $313.07 · $281.76KSEC filing
  • 850 @ $314.25 · $267.11KSEC filing
  • 600 @ $315.32 · $189.19KSEC filing
  • 5,111 @ $316.61 · $1.62MSEC filing
  • 200 @ $317.97 · $63.59KSEC filing
  • 100 @ $318.63 · $31.86KSEC filing
  • 489 @ $320.90 · $156.92KSEC filing
CHIEF FINANCIAL OFFICERCommon StockSale10b5-1317$267.99 / share$84.95KAug 3Filed Aug 5 · 2d laterSEC filing
CHIEF FINANCIAL OFFICERCommon StockSale10b5-1478$274.22 / share$131.08KAug 4Filed Aug 5 · 1d laterSEC filing
CEO AND PRESIDENTCommon StockSale10b5-17 trades3,076avg $266.40 / share$819.43KAug 3Filed Aug 5 · 2d later
7 filings
  • 1,182 @ $267.99 · $316.76KSEC filing
  • 160 @ $259.98 · $41.6KSEC filing
  • 70 @ $261.03 · $18.27KSEC filing
  • 676 @ $263.86 · $178.37KSEC filing
  • 80 @ $265.27 · $21.22KSEC filing
  • 296 @ $267.08 · $79.06KSEC filing
  • 612 @ $268.22 · $164.15KSEC filing
PRESIDENT, CHIEF BUS. OFFICERCommon StockSale10b5-1295$267.99 / share$79.06KAug 3Filed Aug 5 · 2d laterSEC filing
PRESIDENT, CLINICALDIAGNOSTICSCommon StockSale10b5-17 trades3,410avg $265.58 / share$905.63KAug 3Filed Aug 5 · 2d later
7 filings
  • 410 @ $267.99 · $109.88KSEC filing
  • 300 @ $259.98 · $77.99KSEC filing
  • 200 @ $261.49 · $52.3KSEC filing
  • 947 @ $263.94 · $249.95KSEC filing
  • 192 @ $265.28 · $50.93KSEC filing
  • 1,233 @ $267.79 · $330.18KSEC filing
  • 128 @ $268.70 · $34.39KSEC filing
SEC. AND CHIEF LEGAL OFFICERCommon StockSale10b5-1334$267.99 / share$89.51KAug 3Filed Aug 5 · 2d laterSEC filing
EXECUTIVE CHAIRMANCommon StockSale10b5-1731$267.99 / share$195.9KAug 3Filed Aug 5 · 2d laterSEC filing
DirectorCommon StockSale10b5-1109$267.99 / share$29.21KAug 3Filed Aug 5 · 2d laterSEC filing
DirectorCommon StockSale10b5-1288$260.49 / share$75.02KJul 27Filed Jul 29 · 2d laterSEC filing
DirectorCommon StockSale10b5-1191$254.07 / share$48.53KJul 28Filed Jul 29 · 1d laterSEC filing
EXECUTIVE CHAIRMANCommon StockSale10b5-11,718$260.49 / share$447.52KJul 27Filed Jul 29 · 2d laterSEC filing
SEC. AND CHIEF LEGAL OFFICERCommon StockSale10b5-1884$260.49 / share$230.27KJul 27Filed Jul 29 · 2d laterSEC filing
SEC. AND CHIEF LEGAL OFFICERCommon StockSale10b5-11,003$254.07 / share$254.83KJul 28Filed Jul 29 · 1d laterSEC filing
PRESIDENT, CLINICALDIAGNOSTICSCommon StockSale10b5-11,010$260.49 / share$263.1KJul 27Filed Jul 29 · 2d laterSEC filing
PRESIDENT, CLINICALDIAGNOSTICSCommon StockSale10b5-11,204$254.07 / share$305.9KJul 28Filed Jul 29 · 1d laterSEC filing
PRESIDENT, CHIEF BUS. OFFICERCommon StockSale10b5-1782$260.49 / share$203.7KJul 27Filed Jul 29 · 2d laterSEC filing
PRESIDENT, CHIEF BUS. OFFICERCommon StockSale10b5-1931$254.07 / share$236.54KJul 28Filed Jul 29 · 1d laterSEC filing
CEO AND PRESIDENTCommon StockSale10b5-12,190$260.49 / share$570.47KJul 27Filed Jul 29 · 2d laterSEC filing
CEO AND PRESIDENTCommon StockSale10b5-13,580$254.07 / share$909.57KJul 28Filed Jul 29 · 1d laterSEC filing
CHIEF FINANCIAL OFFICERCommon StockSale10b5-1782$260.49 / share$203.7KJul 27Filed Jul 29 · 2d laterSEC filing
CHIEF FINANCIAL OFFICERCommon StockSale10b5-13 trades2,419avg $253.96 / share$614.34KJul 28Filed Jul 29 · 1d later
3 filings
  • 1,241 @ $254.07 · $315.3KSEC filing
  • 1,008 @ $253.77 · $255.8KSEC filing
  • 170 @ $254.33 · $43.24KSEC filing
CHIEF FINANCIAL OFFICERCommon StockSale10b5-11,863$249.38 / share$464.59KJul 29Filed Jul 29 · 0d laterSEC filing
DirectorCommon StockSale10b5-18 trades1,500avg $273.88 / share$410.83KJul 15Filed Jul 17 · 2d later
8 filings
  • 450 @ $273.05 · $122.87KSEC filing
  • 90 @ $274.26 · $24.68KSEC filing
  • 170 @ $275.26 · $46.79KSEC filing
  • 40 @ $276.38 · $11.06KSEC filing
  • 390 @ $273.01 · $106.47KSEC filing
  • 100 @ $273.68 · $27.37KSEC filing
  • 180 @ $274.99 · $49.5KSEC filing
  • 80 @ $276.02 · $22.08KSEC filing
DirectorCommon StockSale10b5-1135$274.82 / share$37.1KJul 15Filed Jul 17 · 2d laterSEC filing
DirectorCommon StockSale10b5-16 trades3,150avg $265.68 / share$836.9KJul 13Filed Jul 15 · 2d later
6 filings
  • 500 @ $262.72 · $131.36KSEC filing
  • 800 @ $264.29 · $211.44KSEC filing
  • 400 @ $265.15 · $106.06KSEC filing
  • 500 @ $266.75 · $133.38KSEC filing
  • 450 @ $267.72 · $120.47KSEC filing
  • 500 @ $268.39 · $134.19KSEC filing
EXECUTIVE CHAIRMANCommon StockSale10b5-11,000$280.00 / share$280KJul 6Filed Jul 8 · 2d laterSEC filing
SEC. AND CHIEF LEGAL OFFICERCommon StockSale10b5-112 trades16,800avg $272.29 / share$4.57MJul 1Filed Jul 6 · 5d later
12 filings
  • 1,568 @ $266.79 · $418.33KSEC filing
  • 3,705 @ $268.11 · $993.33KSEC filing
  • 1,932 @ $268.99 · $519.69KSEC filing
  • 484 @ $269.87 · $130.62KSEC filing
  • 1,357 @ $270.96 · $367.7KSEC filing
  • 454 @ $272.14 · $123.55KSEC filing
  • 500 @ $274.19 · $137.1KSEC filing
  • 1,100 @ $275.20 · $302.72KSEC filing
  • 1,400 @ $276.24 · $386.74KSEC filing
  • 2,045 @ $277.29 · $567.06KSEC filing
  • 1,955 @ $278.25 · $543.97KSEC filing
  • 300 @ $278.77 · $83.63KSEC filing
PRESIDENT, CLINICALDIAGNOSTICSCommon StockSale10b5-13 trades3,000avg $272.90 / share$818.71KJul 1Filed Jul 6 · 5d later
3 filings
  • 100 @ $267.19 · $26.72KSEC filing
  • 2,600 @ $272.99 · $709.77KSEC filing
  • 300 @ $274.06 · $82.22KSEC filing
SEC. AND CHIEF LEGAL OFFICERCommon StockSale10b5-14 trades33,600avg $251.65 / share$8.46MJun 24Filed Jun 26 · 2d later
4 filings
  • 16,204 @ $250.25 · $4.06MSEC filing
  • 1,200 @ $251.60 · $301.91KSEC filing
  • 5,066 @ $252.31 · $1.28MSEC filing
  • 11,130 @ $253.39 · $2.82MSEC filing
DirectorCommon StockSale10b5-116,530$250.00 / share$4.13MJun 24Filed Jun 26 · 2d laterSEC filing
DirectorCommon StockSale10b5-19 trades1,500avg $219.87 / share$329.81KJun 17Filed Jun 22 · 5d later
9 filings
  • 256 @ $218.14 · $55.84KSEC filing
  • 128 @ $219.26 · $28.06KSEC filing
  • 122 @ $220.93 · $26.95KSEC filing
  • 244 @ $221.46 · $54.04KSEC filing
  • 267 @ $218.18 · $58.25KSEC filing
  • 96 @ $219.13 · $21.04KSEC filing
  • 71 @ $220.46 · $15.65KSEC filing
  • 301 @ $221.39 · $66.64KSEC filing
  • 15 @ $222.14 · $3.33KSEC filing
DirectorCommon StockSale10b5-12,964$216.78 / share$642.54KJun 16Filed Jun 17 · 1d laterSEC filing
DirectorCommon StockSale10b5-14 trades3,150avg $211.14 / share$665.09KJun 15Filed Jun 17 · 2d later
4 filings
  • 1,750 @ $210.29 · $368.01KSEC filing
  • 600 @ $211.34 · $126.8KSEC filing
  • 500 @ $212.42 · $106.21KSEC filing
  • 300 @ $213.54 · $64.06KSEC filing
EXECUTIVE CHAIRMANCommon StockSale10b5-111 trades50,000avg $214.03 / share$10.7MJun 12Filed Jun 16 · 4d later
11 filings
  • 2,536 @ $209.50 · $531.28KSEC filing
  • 3,267 @ $210.30 · $687.05KSEC filing
  • 2,957 @ $211.61 · $625.74KSEC filing
  • 12,142 @ $212.27 · $2.58MSEC filing
  • 5,034 @ $213.43 · $1.07MSEC filing
  • 5,707 @ $214.35 · $1.22MSEC filing
  • 3,161 @ $215.38 · $680.82KSEC filing
  • 7,182 @ $216.51 · $1.55MSEC filing
  • 4,276 @ $217.32 · $929.28KSEC filing
  • 2,133 @ $218.17 · $465.36KSEC filing
  • 1,605 @ $219.36 · $352.07KSEC filing
EXECUTIVE CHAIRMANCommon StockSale10b5-110 trades50,000avg $214.91 / share$10.75MJun 15Filed Jun 16 · 1d later
10 filings
  • 831 @ $209.83 · $174.37KSEC filing
  • 1,832 @ $210.73 · $386.06KSEC filing
  • 1,237 @ $211.81 · $262.01KSEC filing
  • 5,097 @ $212.84 · $1.08MSEC filing
  • 7,836 @ $213.88 · $1.68MSEC filing
  • 10,338 @ $214.72 · $2.22MSEC filing
  • 11,877 @ $215.91 · $2.56MSEC filing
  • 6,741 @ $216.81 · $1.46MSEC filing
  • 3,811 @ $217.60 · $829.28KSEC filing
  • 400 @ $218.72 · $87.49KSEC filing
DirectorCommon StockSale4 trades11,000avg $217.21 / share$2.39MJun 5Filed Jun 9 · 4d later
4 filings
  • 3,016 @ $216.06 · $651.65KSEC filing
  • 4,694 @ $217.30 · $1.02MSEC filing
  • 3,174 @ $218.11 · $692.28KSEC filing
  • 116 @ $218.82 · $25.38KSEC filing
CEO AND PRESIDENTCommon StockSale10b5-114 trades41,124avg $221.03 / share$9.09MJun 4Filed Jun 5 · 1d later
14 filings
  • 832 @ $212.42 · $176.73KSEC filing
  • 2,503 @ $213.44 · $534.25KSEC filing
  • 1,300 @ $214.83 · $279.28KSEC filing
  • 5,499 @ $216.13 · $1.19MSEC filing
  • 2,351 @ $217.04 · $510.26KSEC filing
  • 1,742 @ $218.28 · $380.25KSEC filing
  • 2,758 @ $219.08 · $604.22KSEC filing
  • 2,400 @ $220.19 · $528.45KSEC filing
  • 2,006 @ $222.25 · $445.83KSEC filing
  • 6,500 @ $223.34 · $1.45MSEC filing
  • 1,443 @ $223.91 · $323.1KSEC filing
  • 1,630 @ $224.99 · $366.74KSEC filing
  • 6,751 @ $226.15 · $1.53MSEC filing
  • 3,409 @ $226.97 · $773.74KSEC filing
PRESIDENT, CLINICALDIAGNOSTICSCommon StockSale10b5-14 trades3,000avg $218.43 / share$655.29KJun 1Filed Jun 3 · 2d later
4 filings
  • 1,802 @ $217.52 · $391.97KSEC filing
  • 413 @ $218.84 · $90.38KSEC filing
  • 213 @ $219.34 · $46.72KSEC filing
  • 572 @ $220.67 · $126.22KSEC filing
DirectorCommon StockSale6 trades78,000avg $220.31 / share$17.18MJun 1Filed Jun 3 · 2d later
6 filings
  • 26,411 @ $218.69 · $5.78MSEC filing
  • 10,100 @ $219.78 · $2.22MSEC filing
  • 21,304 @ $220.94 · $4.71MSEC filing
  • 14,885 @ $221.58 · $3.3MSEC filing
  • 2,850 @ $222.79 · $634.96KSEC filing
  • 2,450 @ $223.83 · $548.37KSEC filing
PRESIDENT, CLINICALDIAGNOSTICSCommon StockSale10b5-11,652$202.84 / share$335.09KMay 26Filed May 28 · 2d laterSEC filing
PRESIDENT, CHIEF BUS. OFFICERCommon StockSale10b5-11,438$202.84 / share$291.68KMay 26Filed May 28 · 2d laterSEC filing
DirectorCommon StockSale10b5-15 trades3,150avg $208.60 / share$657.1KMay 8Filed May 15 · 7d later
5 filings
  • 200 @ $205.43 · $41.09KSEC filing
  • 900 @ $207.24 · $186.52KSEC filing
  • 700 @ $208.13 · $145.69KSEC filing
  • 200 @ $209.57 · $41.91KSEC filing
  • 1,150 @ $210.35 · $241.9KSEC filing
DirectorCommon StockSale10b5-18 trades1,500avg $201.56 / share$302.35KMay 13Filed May 15 · 2d later
8 filings
  • 85 @ $199.52 · $16.96KSEC filing
  • 345 @ $201.11 · $69.38KSEC filing
  • 290 @ $202.58 · $58.75KSEC filing
  • 30 @ $202.84 · $6.09KSEC filing
  • 96 @ $199.43 · $19.15KSEC filing
  • 360 @ $201.19 · $72.43KSEC filing
  • 285 @ $202.68 · $57.76KSEC filing
  • 9 @ $203.30 · $1.83KSEC filing
EXECUTIVE CHAIRMANCommon StockSale10b5-1722$206.16 / share$148.85KMay 4Filed May 6 · 2d laterSEC filing
EXECUTIVE CHAIRMANCommon StockSale10b5-14 trades6,986avg $213.77 / share$1.49MMay 5Filed May 6 · 1d later
4 filings
  • 2,887 @ $206.77 · $596.94KSEC filing
  • 1,454 @ $241.39 · $350.98KSEC filing
  • 1,697 @ $206.77 · $350.89KSEC filing
  • 948 @ $205.22 · $194.55KSEC filing
CHIEF FINANCIAL OFFICERCommon StockSale10b5-1313$206.16 / share$64.53KMay 1Filed May 5 · 4d laterSEC filing
CHIEF FINANCIAL OFFICERCommon StockSale10b5-1482$210.49 / share$101.46KMay 4Filed May 5 · 1d laterSEC filing
DirectorCommon StockSale10b5-1107$206.16 / share$22.06KMay 1Filed May 5 · 4d laterSEC filing
PRESIDENT, CLINICALDIAGNOSTICSCommon StockSale10b5-17 trades3,405avg $203.69 / share$693.56KMay 1Filed May 5 · 4d later
7 filings
  • 405 @ $206.16 · $83.49KSEC filing
  • 560 @ $200.95 · $112.53KSEC filing
  • 520 @ $201.60 · $104.83KSEC filing
  • 505 @ $203.32 · $102.67KSEC filing
  • 865 @ $204.47 · $176.86KSEC filing
  • 400 @ $205.31 · $82.12KSEC filing
  • 150 @ $206.93 · $31.04KSEC filing
PRESIDENT, CHIEF BUS. OFFICERCommon StockSale10b5-1291$206.16 / share$59.99KMay 1Filed May 5 · 4d laterSEC filing
CEO AND PRESIDENTCommon StockSale10b5-1902$206.16 / share$185.96KMay 1Filed May 5 · 4d laterSEC filing
SEC. AND CHIEF LEGAL OFFICERCommon StockSale10b5-1330$206.16 / share$68.03KMay 1Filed May 5 · 4d laterSEC filing
CHIEF FINANCIAL OFFICERCommon StockSale10b5-12 trades1,993avg $204.14 / share$406.86KApr 27Filed Apr 29 · 2d later
2 filings
  • 771 @ $203.75 · $157.09KSEC filing
  • 1,222 @ $204.39 · $249.76KSEC filing
CHIEF FINANCIAL OFFICERCommon StockSale10b5-15 trades3,070avg $193.74 / share$594.79KApr 29Filed Apr 29 · 0d later
5 filings
  • 300 @ $190.12 · $57.03KSEC filing
  • 500 @ $192.13 · $96.06KSEC filing
  • 1,000 @ $193.78 · $193.78KSEC filing
  • 1,070 @ $194.82 · $208.46KSEC filing
  • 200 @ $197.26 · $39.45KSEC filing
CEO AND PRESIDENTCommon StockSale10b5-12 trades5,838avg $204.14 / share$1.19MApr 27Filed Apr 29 · 2d later
2 filings
  • 2,272 @ $203.75 · $462.92KSEC filing
  • 3,566 @ $204.39 · $728.85KSEC filing
PRESIDENT, CHIEF BUS. OFFICERCommon StockSale10b5-12 trades1,688avg $204.10 / share$344.52KApr 27Filed Apr 29 · 2d later
2 filings
  • 771 @ $203.75 · $157.09KSEC filing
  • 917 @ $204.39 · $187.43KSEC filing
PRESIDENT, CLINICALDIAGNOSTICSCommon StockSale10b5-12 trades2,182avg $204.10 / share$445.34KApr 27Filed Apr 29 · 2d later
2 filings
  • 997 @ $203.75 · $203.14KSEC filing
  • 1,185 @ $204.39 · $242.2KSEC filing
SEC. AND CHIEF LEGAL OFFICERCommon StockSale10b5-12 trades1,861avg $204.09 / share$379.81KApr 27Filed Apr 29 · 2d later
2 filings
  • 873 @ $203.75 · $177.87KSEC filing
  • 988 @ $204.39 · $201.94KSEC filing
DirectorCommon StockSale10b5-12 trades473avg $204.00 / share$96.49KApr 27Filed Apr 29 · 2d later
2 filings
  • 285 @ $203.75 · $58.07KSEC filing
  • 188 @ $204.39 · $38.43KSEC filing
DirectorCommon StockSale10b5-12 trades3,071avg $196.42 / share$603.2KApr 29Filed Apr 29 · 0d later
2 filings
  • 2,266 @ $196.22 · $444.62KSEC filing
  • 805 @ $196.99 · $158.58KSEC filing
DirectorCommon StockSale10b5-12 trades1,500avg $199.63 / share$299.44KApr 17Filed Apr 21 · 4d later
2 filings
  • 750 @ $199.66 · $149.75KSEC filing
  • 750 @ $199.59 · $149.69KSEC filing
SEC. AND CHIEF LEGAL OFFICERCommon StockSale10b5-15 trades8,400avg $203.31 / share$1.71MApr 1Filed Apr 3 · 2d later
5 filings
  • 300 @ $200.79 · $60.24KSEC filing
  • 1,778 @ $202.01 · $359.17KSEC filing
  • 3,213 @ $203.07 · $652.47KSEC filing
  • 1,200 @ $203.83 · $244.59KSEC filing
  • 1,909 @ $205.00 · $391.35KSEC filing
PRESIDENT, CLINICALDIAGNOSTICSCommon StockSale10b5-13 trades3,000avg $202.30 / share$606.9KApr 1Filed Apr 3 · 2d later
3 filings
  • 1,048 @ $201.32 · $210.98KSEC filing
  • 1,000 @ $202.36 · $202.36KSEC filing
  • 952 @ $203.31 · $193.55KSEC filing

Congress transactions 1

All Congress filings
Purchase disclosed

Natera, Inc. - Common Stock (NTRA) · Stock

The filing reports a purchase for a joint account.

Josh Gottheimer official portraitJosh GottheimerReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
September 22, 2025
Filed October 15, 2025 · 23d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001604821
Latest public acceptance
Oct 3, 2026, 01:35 AM UTC
Score calculated
Oct 8, 2026, 12:08 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.